Leukemia Clinical Trials

Showing 4421-4440 of 10,987 trials

Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC

NCT05011487

This is a phase II, single-arm, multi-center study of neoadjuvant osimertinib in combination with chemotherapy for the treatment of patients with resectable EGFR-mutant stage III (N2) non-squamous non-small cell lung cancer

Non-Small Cell Lung Cancer

Sun Yat-sen University30 participantsStarted Aug 2021

Guangzhou, Guangdong, China

TERMINATEDPhase 1/2

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

NCT03422679

This is a phase I/II, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of CB-103.

Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more

Cellestia Biotech AG79 participantsStarted Dec 2017

Santa Monica, California, United States • Boston, Massachusetts, United States • Houston, Texas, United States +14 more locations

Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Related Searches

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)

ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT

Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients

Efficacy and Safety of IBI110 in Combination With Sintilimab Versus Sintilimab Alone in Neoadjuvant and Adjuvant Therapy of Radically Resectable Non-small Cell Lung Cancer

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

Acceptability of Hip Protector Airbags in Older People

The p53 Breast Cancer Trial

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients

Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)

Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy

Collection of Blood Samples in Patients With Non-small Cell Lung Cancer

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure